skip to main content

Our M&A lawyers are among the most experienced and effective in the world. We represent many of the world's largest publicly traded and privately held companies, as well as leading private equity firms, hedge funds, financial advisors and other financial institutions and investors on their most important merger, acquisitions and takeover transactions.

Publications

Is the Coronavirus a Material Adverse Effect?

Currently, the impacts of the coronavirus (COVID-19) would not likely trigger the typical MAE termination right. However, this may change depending on the outbreak’s duration, disproportionate industry or company impacts and whether MAE provisions become more tailored to address this issue.  In ongoing negotiations, careful consideration should be given to crafting MAE provisions in light of the outbreak.

» more

Awards & Recognition

Bob Schumer and Paul Basta Recognized as “Dealmakers of the Year” by The American Lawyer

Corporate partner Bob Schumer and restructuring partner Paul Basta have been named American Lawyer “Dealmakers of the Year.”

» more

Client News

General Electric Completes Sale of BioPharma Business to Danaher for $21.4 Billion

Paul, Weiss advised General Electric in the sale of its BioPharma business to Danaher Corporation for $21.4 billion.

» more

Client News

AWARDS & RECOGNITION

Law360 Recognizes Paul, Weiss M&A Practice Among the Year’s Best

Paul, Weiss was recognized by Law360 with a “Practice Group of the Year” award in the Mergers & Acquisitions category.

» more

Awards & Recognition

Rachael Coffey Profiled by The Deal as a Rising Star

Corporate partner Rachael Coffey was profiled by The Deal as a “Rising Star” in the ranks of M&A lawyers at major law firms.

» more

Client News

IBM Completes Landmark $34 Billion Acquisition of Red Hat

Paul, Weiss advised International Business Machines Corp. in its all-cash acquisition of Red Hat Inc., creating the world’s largest hybrid cloud provider.

» more

Client News

Elanco to Acquire Bayer’s Animal Health Business in $7.6 Billion Deal

Paul, Weiss is representing Elanco Animal Health Incorporated in its $7.6 billion cash-and-stock acquisition of the animal health business of Bayer AG, creating the world’s second-largest animal health business.

» more

© 2020 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy